Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA–IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study

Ye, Jing-RenJing-RenYePEI-HSING CHENJEN-HAO CHUANGMONG-WEI LINTUNG-MING TSAIHSAO-HSUN HSUJIN-SHING CHEN2022-07-292022-07-2920222296-875Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85127615718&doi=10.3389%2ffsurg.2022.816018&partnerID=40&md5=7a9c30d2cc4c54c74b6950f32633025ehttps://scholars.lib.ntu.edu.tw/handle/123456789/616006enTreatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA–IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Studyjournal article10.3389/fsurg.2022.8160182-s2.0-85127615718